Carole Nuechterlein - Head of Roche Venture Fund @ Roche Venture Fund

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

100,806

Primary Job Title Head of Roche Venture Fund
Primary Organization
Roche Venture Fund

Location Basel, Basel-Stadt, Switzerland
Regions Europe, Middle East, and Africa (EMEA)
Gender Female

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Carole L. Nuechterlein serves as a Head at Roche Venture Fund. She attended University of Michigan.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Splice Bio	Roche Venture Fund	—	Series B - Splice Bio	obfuscated obfuscation
obfuscated obfuscation	Enthera	Roche Venture Fund	Yes	Series A - Enthera	obfuscated obfuscation
obfuscated obfuscation	Arch Oncology	Roche Venture Fund	Yes	Series A - Arch Oncology	obfuscated obfuscation
obfuscated obfuscation	Second Genome	Roche Venture Fund	Yes	Series B - Second Genome	obfuscated obfuscation
obfuscated obfuscation	AveXis	Roche Venture Fund	No	Series D - AveXis	obfuscated obfuscation
obfuscated obfuscation	Lysosomal Therapeutics	Roche Venture Fund	—	Series A - Lysosomal Therapeutics	obfuscated obfuscation
obfuscated obfuscation	AveXis	Roche Venture Fund	Yes	Series C - AveXis	obfuscated obfuscation
obfuscated obfuscation	Lysosomal Therapeutics	Roche Venture Fund	—	Seed Round - Lysosomal Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Alios BioPharma	Roche Venture Fund	—	Series B - Alios BioPharma	obfuscated obfuscation
obfuscated obfuscation	Alios BioPharma	Roche Venture Fund	—	Series A - Alios BioPharma	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Carole Nuechterlein

has

current jobs as

Head of Roche Venture Fund

Roche Venture Fund

and

Senior Vice President

SangStat

. Additionally,

Carole Nuechterlein

has had

past jobs including

Director of Legal Affairs

Roche

Roche Venture Fund Head of Roche Venture Fund2001
SangStat Senior Vice President2001

Organization Name	Title At Company	Start Date	End Date
Roche	Director of Legal Affairs	—	—
Syntex Corporation	Team Member, Syntex	—	—
SangStat	Vice President & General Counsel	Oct 1998	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Carole Nuechterlein

holds

board and advisor roles including

Board of Director

Splice Bio

Board Member

Enthera

, and

Board Of Director

Arch Oncology

Splice Bio Board of DirectorJun 11, 2025
Enthera Board Member
Arch Oncology Board Of Director
Ambrx Observer
Lysosomal Therapeutics Board of Directors
Alios BioPharma Board Observer

Organization Name	Title At Company	Start Date	End Date
Epic	Board Observer	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Switzerland Late Stage Venture Investors	64,381
Investors Active in Switzerland	8,368
Europe, Middle East, and Africa (EMEA) Corporate VC Investors	29,220
Basel-Stadt Investors	83,958
Corporate VC Investors with Investments in Europe, Middle East, and Africa (EMEA)	23,507
Late Stage Venture Investors Corporate VC Investors	31,598
Switzerland Corporate VC Investors	74,665
Europe Corporate VC Investors	39,927
Europe, Middle East, and Africa (EMEA) Late Stage Venture Investors	6,940
Late Stage Venture Investors with Investments in Switzerland	19,330

Education

Carole Nuechterlein

studied at

University of Michigan

and

Valparaiso University

University of Michigan JDunknown
Valparaiso University Undergraduateunknown